Richard S Levy Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard S Levy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Richard S Levy for February 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 13.34 | 417 | 5,563 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 13.34 | 14,583 | 194,537 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 24,787 | 233,246 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 1,945 | 23,301 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 9,138 | 109,473 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 12,300 | 115,743 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 25,862 | 309,827 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 9.41 | 47,913 | 450,861 | 24,787 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 3.11 | 61,096 | 190,009 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 11.98 | 33,055 | 395,999 | 0 | |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 66.13 | 39,787 | 2,631,114 | 4,301 | 44.1 K to 4.3 K (-90.24 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 13.34 | 417 | 5,563 | 44,088 | 43.7 K to 44.1 K (+0.95 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 13.34 | 14,583 | 194,537 | 43,671 | 29.1 K to 43.7 K (+50.13 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 24,787 | 233,246 | 29,088 | 4.3 K to 29.1 K (+576.31 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 66.38 | 191,309 | 12,699,091 | 4,301 | 195.6 K to 4.3 K (-97.80 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 1,945 | 23,301 | 195,610 | 193.7 K to 195.6 K (+1.00 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 9,138 | 109,473 | 193,665 | 184.5 K to 193.7 K (+4.95 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 12,300 | 115,743 | 184,527 | 172.2 K to 184.5 K (+7.14 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 25,862 | 309,827 | 172,227 | 146.4 K to 172.2 K (+17.67 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 9.41 | 47,913 | 450,861 | 146,365 | 98.5 K to 146.4 K (+48.67 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 3.11 | 61,096 | 190,009 | 98,452 | 37.4 K to 98.5 K (+163.55 %) |
Feb 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 11.98 | 33,055 | 395,999 | 37,356 | 4.3 K to 37.4 K (+768.54 %) |